Miracle V A
AACN Clin Issues. 1996 Nov;7(4):543-9. doi: 10.1097/00044067-199611000-00008.
Chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death in Americans. In addition, COPD significantly affects the quality of life of afflicted patients. Historically, the treatment for emphysema has been primarily medical and includes medications, smoking cessation, and pulmonary rehabilitation. Recently a surgical procedure, lung volume reduction surgery (LVRS) has been reintroduced as a treatment for end-stage lung disease, primarily emphysema. In LVRS, wedge resections are performed to reduce the size of the lungs and improve alveolar functioning. This article describes the evaluation of patients who undergo LVRS and the associated pathophysiology in addition to the surgical procedure, inclusion and exclusion criteria, pre- and postoperative care, potential complications, and preliminary data associated with the procedure at one facility. Although LVRS is not a procedure for all patients with emphysema, it may significantly improve the quality of life of selected patients.
慢性阻塞性肺疾病(COPD)是美国人死亡的第四大主要原因。此外,COPD严重影响患病患者的生活质量。从历史上看,肺气肿的治疗主要是药物治疗,包括用药、戒烟和肺康复。最近,一种外科手术——肺减容手术(LVRS)被重新引入作为终末期肺病(主要是肺气肿)的治疗方法。在LVRS中,进行楔形切除术以减小肺的大小并改善肺泡功能。本文除了介绍手术过程、纳入和排除标准、术前和术后护理、潜在并发症以及一家机构与该手术相关的初步数据外,还描述了接受LVRS患者的评估以及相关的病理生理学。虽然LVRS并非适用于所有肺气肿患者,但它可能会显著改善部分患者的生活质量。